Immune design corp. (IMDZ)
Balance Sheet / TTM
Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Dec'13
Assets
Current assets:
Cash and cash equivalents

77,941

68,535

73,430

72,172

72,454

28,369

35,311

27,918

45,214

70,434

50,531

54,762

112,921

120,490

128,998

60,230

75,354

83,388

18,003

30,387

Short-term investments

17,946

-

-

-

68,653

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Short-term investments

-

38,853

46,795

58,706

-

35,970

45,964

61,991

62,041

42,037

42,058

46,068

0

-

-

-

-

-

-

-

Accounts receivable

705

780

660

340

647

520

495

603

517

7,494

377

13

972

3,143

879

1,578

1,970

50

1,038

87

Inventory, Net

92

1,354

900

674

684

608

624

576

607

709

724

705

13

307

434

27

25

481

19

17

Prepaid expenses

1,755

2,728

2,111

2,514

1,571

2,437

1,323

1,911

2,546

-

3,534

2,894

1,654

1,425

432

781

633

788

969

179

Restricted cash

0

0

0

0

6,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

6,000

6,000

6,000

0

-

-

-

-

-

-

-

-

-

-

-

Other receivables

-

243

88

97

-

3,113

123

146

3,156

-

-

-

0

-

-

-

-

-

-

-

Prepaid expenses and other current assets

-

-

-

-

-

-

-

-

-

4,552

-

-

-

-

-

-

-

-

-

-

Other assets

1,786

-

-

-

3,134

-

-

-

-

-

79

86

-

-

103

-

-

-

-

-

Total current assets

100,225

112,493

123,984

134,503

153,143

77,017

89,840

99,145

114,081

125,226

97,303

104,528

115,560

125,365

130,846

62,616

77,982

84,707

20,029

30,670

Property and equipment, net

535

492

548

611

491

502

506

537

414

433

488

528

585

532

496

481

401

309

290

295

Other assets

-

-

-

-

-

550

525

-

-

-

-

-

-

-

-

-

-

-

-

-

Security deposit

200

200

200

200

200

-

-

200

0

-

-

-

-

-

-

-

-

-

-

-

Deferred offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

200

-

-

1,765

-

Total assets

100,960

113,185

124,732

135,314

153,834

78,069

90,871

99,882

114,495

125,659

97,791

105,056

116,145

125,897

131,342

63,297

78,383

85,016

22,084

30,965

Liabilities and stockholders’ equity
Current liabilities:
Accounts payable

1,478

2,819

3,156

2,630

2,334

2,552

4,246

3,314

4,559

4,863

3,528

1,765

3,074

2,679

2,016

2,423

6,903

3,070

1,369

866

Accrued liabilities

7,367

5,764

4,745

3,721

6,186

5,581

5,721

4,163

4,935

4,696

7,113

4,133

3,959

3,948

4,138

2,506

5,001

2,845

1,452

1,082

Accrued litigation-related settlement

0

0

0

0

6,000

7,250

7,250

7,250

7,250

4,600

-

-

0

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

7

35

26

2,519

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue and other current liabilities

-

-

-

-

-

-

-

-

-

-

23

37

78

52

49

47

43

40

36

27

Deferred revenue and other current liabilities

-

-

-

-

-

-

-

-

-

2,931

-

-

-

-

-

-

-

-

-

-

Total current liabilities

8,845

8,583

7,901

6,351

14,520

15,390

17,252

14,753

19,263

17,090

10,664

5,935

7,111

6,679

6,203

4,976

11,947

5,955

2,857

1,975

Accrued litigation-related settlement, noncurrent

-

-

-

-

-

-

-

-

-

1,250

-

-

-

-

-

-

-

-

-

-

Other noncurrent liabilities

110

108

107

105

102

91

79

63

56

60

63

67

41

49

61

-

90

-

-

-

Other noncurrent liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

73

-

65

76

94

Convertible preferred stock warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

7,486

3,336

Commitments and contingencies (Note 9)

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Convertible preferred stock, $0.001 par value per share; 10,000,000 shares authorized at March 31, 2015 (unaudited) and December 31, 2014; zero shares issued and outstanding at March 31, 2015 (unaudited) and December 31, 2014; liquidation preference of zero at March 31, 2015 (unaudited) and December 31, 2014

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

81,394

81,394

Stockholders’ equity:
Common stock, $0.001 par value per share; 100,000,000 authorized at December 31, 2018 and 2017; 48,210,520 and 48,068,650 shares issued and outstanding at December 31, 2018 and 2017, respectively

48

48

48

48

48

26

26

26

25

25

20

20

20

20

20

17

17

17

3

3

Preferred stock, $0.001 par value; 10,000,000 shares authorized; no shares issued or outstanding

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

-

0

-

-

-

Additional paid-in capital

382,474

381,379

379,576

377,934

374,970

286,353

283,918

281,602

278,913

276,519

243,863

241,516

239,181

237,242

235,744

158,400

157,092

156,622

1,229

775

Accumulated deficit

-290,515

-276,914

-262,865

-249,057

-235,757

-223,777

-210,361

-196,515

-183,738

-169,292

-156,849

-142,502

-130,208

-118,093

-110,686

-100,169

-90,763

-77,643

-70,961

-56,612

Accumulated other comprehensive loss

-2

-19

-35

-67

-49

-14

-43

-47

-24

7

30

20

0

-

-

-

-

-

-

-

Total stockholders’ equity

92,005

104,494

116,724

128,858

139,212

62,588

73,540

85,066

95,176

107,259

87,064

99,054

108,993

119,169

125,078

58,248

66,346

78,996

-69,729

-55,834

Total liabilities and stockholders’ equity

100,960

113,185

124,732

135,314

153,834

78,069

90,871

99,882

114,495

125,659

97,791

105,056

116,145

125,897

131,342

63,297

78,383

85,016

22,084

30,965